Skip to content

OMDA OMDA Long-Term Debt

Discontinued — last reported Q4 '25

Long-Term Debt at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$601.77M+94.9%
Insulet logo
InsuletPODD
$948.1M-44.1%
AdaptHealth logo
AdaptHealthAHCO
$1.8B-7.3%
Eli Lilly logo
Eli LillyLLY
$39.37B+14.1%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$49.68M-15.3%

Other financials

Income statement

See full
Revenue$78.0M+42.0%
Gross profit$48.7M+52.6%
Operating income-$4.8M+43.1%
Net income-$3.0M+68.6%
EPS (diluted)-$0.05+95.7%

Balance sheet

See full
Cash & equivalents$211.8M+257%
Total debt$30.0M
Total equity$234.1M+160%
Total assets$302.8M

Cash flow

See full
Operating cash flow-$11.8M+26.6%
CapEx$78.0K-75.2%
Free cash flow-$11.9M+27.5%

Valuation

See full
Market cap$1.11B+23.8%
P/S3.9×-0.4×

Profitability

See full
Gross margin66.3%+4.4pp
Operating margin-9.6%-4.0pp
Net margin-11.3%-4.6pp
FCF margin-40.8%

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.1×
Current ratio3.9×

Where this comes from

Reported directly by OMDA in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebt.

The official record: OMDA’s 10-K, filed March 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about OMDA's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OMDA's long-term debt?
OMDA (OMDA) reported long-term debt of $0 in Q4 2025.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.